Replies to post #281 on Bottom Swing Plays Chat

[Boxsterfan]

This is Bottom Swing Plays Chat, right? Recent Bottom Swing on SLS was a brief dip to $0.81 (for about 2 minutes) a few weeks back. Didn't get that.

I'm buying SLS now because

1. Phase 3 Regal Trial data imminent for drug GPS.
2. In the last 30 days, their drug SLS009 has received two (2) Priority Review Vouchers for Rare Pediatic Disease Designation (RPDD) because the drug has a 99%+ overall response rate in patients.
3. Commercial team left in March 2024. Company is looking to be bought out and actively seeking such. Abbvie, Merck, Novartis are my guesses for interested parties.